Skip to main content
. 2017 Jul 7;16:1–3. doi: 10.1016/j.ijcha.2017.06.001

Table 1.

Baseline patient demographics.

Variable Entire cohort 2008–2009 2010–2011 2012–2014 p value
Age (years) 82 ± 5 83 ± 4 82 ± 4 81 ± 5 0.6
Male 83 (56%) 25 (64%) 19 (47%) 39 (61%) 0.05
NYHA 3.3 ± 0.6 3.4 ± 0.2 3.2 ± 0.5 3.3 ± 0.7 0.8
CCS 0.4 ± 0.8 0.4 ± 0.7 0.4 ± 0.7 0.4 ± 1.0 0.7
GRF ml/min 58 ± 22 54 ± 19 66 ± 22 57 ± 25 0.07
GFR < 30 ml/min 29 (20%) 7 (19%) 5 (14%) 17 (25%) 0.2
Pacemaker 17 (12%) 7 (18%) 3 (8%) 7 (11%) 0.2
Atrial fibrillation 25 (17%) 6 (15%) 3 (8%) 16 (25%) 0.3
Ejection fraction 50 ± 9 51 ± 10 49 ± 9 50 ± 8 0.6
AVA 0.8 ± 0.7 0.7 ± 0.2 0.7 ± 0.2 0.9 ± 0.9 0.2
AR grade 1.1 ± 0.9 0.9 ± 0.6 0.8 ± 0.6 1.3 ± 1.1 0.02
MR grade 1.1 ± 0.8 1.3 ± 0.5 1.0 ± 0.3 1.4 ± 0.7 0.5
EURO II score 9.1 ± 5 9.1 ± 6.3 9.4 ± 3.2 8.2 ± 3.7 0.4

Data is expressed as mean ± standard deviation or number of patients (%).

AVA is aortic valve area-cm2; AR is Aortic Regurgitation; MR is Mitral Regurgitation; EF is ejection fraction measured by Simpsons.